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Abstract
Objectives—Few studies have been conducted in Africa to assess prevalence of sexually 
transmitted infections (STIs) and risk factors among men who have sex with men (MSM). We 
report findings from the first behavioural survey to include STI testing among MSM in Kampala, 
Uganda.
Methods—Respondent-driven sampling (RDS) was used to recruit MSM for a biobehavioural 
survey. Eligible participants were men who reported anal sex with another man in the previous 3 
months, were 18 years or older, and resided in Kampala. Information was collected on 
demographics, sexual behaviour, alcohol and drug use, and STI symptoms. Blood, urine and rectal 
specimens were tested for syphilis, HIV, rectal and urethral gonorrhoea, and chlamydia. Analyses 
weighted for RDS were conducted to assess associations with STI diagnosis.
Results—A total of 295 MSM participated in the survey. Almost half (weighted percentage: 
47.3%) reported STI symptoms in the last 6 months and 12.9% tested HIV-positive. Prevalence of 
non-HIV STI was 13.5%; syphilis prevalence was 9.0%. Adjusting for age and education, STI was 
associated with HIV (adjusted OR (AOR)=3.46, 95% CI 1.03 to 11.64), alcohol use before sex 
(AOR=4.99, 95% CI 1.86 to 13.38) and having sold sex in the last 3 months (AOR=3.17, 95% CI 
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1.25 to 8.07), and inversely associated with having anonymous sex partners (AOR=0.20, 95% CI 
0.07 to 0.61).
Conclusions—We observed high levels of self-reported STI symptoms and STI prevalence 
associated with alcohol use and HIV among MSM in Kampala. Public health interventions 
supporting MSM are needed to address STI risk and facilitate access to diagnosis and treatment 
services.
Introduction
Sexually transmitted infections (STIs) such as syphilis, gonorrhoea and chlamydia cause 
significant global morbidity and mortality and have been associated with increased risk of 
HIV transmission.1 It is estimated that 340 million new cases of curable STIs occur every 
year among men and women aged 15–49 years throughout the world. Of these, an estimated 
4 million new cases of syphilis occur in sub-Saharan Africa, a third of the 12 million new 
syphilis cases estimated worldwide.2 Similarly, of 92 million new cases of chlamydia and 62 
million new cases of gonorrhoea globally, sub-Saharan Africa accounted for 16 million 
(17.4%) and 17 million (27.4%), respectively. The 2011 Uganda AIDS Indicator Survey 
reported a syphilis prevalence of 1.8% among men in the general population aged 15–49 
years. The same survey found that 20.6% of sexually active men reported having had a STI 
or STI symptoms in the previous year.3
Men who have sex with men (MSM) have been studied as a key population at higher risk for 
HIV and STIs; however, few studies have been conducted among MSM in Africa. 
Homosexuality and same-sex sexual behaviours are illegal and highly stigmatised in 
Uganda, presenting substantial challenges to public health surveillance and intervention 
efforts among the MSM population. In 2004, a study was conducted in Kampala that 
demonstrated the existence of a local MSM population and observed sexual risk behaviours 
in this group.4 The study found high rates of unprotected receptive anal intercourse and 
commercial sex, with low perception of risk for HIV infection; however, no biological 
testing was conducted to assess prevalence of HIVor STIs.
A follow-up study conducted in 2008–2009 was the first behavioural survey to include STI 
and HIV testing among MSM in Kampala.5 The objective of this study was to establish a 
periodic HIV surveillance system that would inform and evaluate the impact of interventions 
for MSM and other key populations. We present here findings on STI prevalence and 
associated risk behaviours from this first round of biobehavioural surveillance among MSM.
Methods
Respondent-driven sampling (RDS) was used to recruit MSM in Kampala, Uganda between 
May 2008 and April 2009. RDS is a type of chain referral sampling that adjusts for 
recruitment patterns and social network size to arrive at population-level estimates.67 
Eligible participants were men who reported having anal sex with another man in the 
previous 3 months, were aged 18 years or older, spoke English or Luganda, and resided in 
greater Kampala.
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We started sampling with eight diverse seeds purposively selected by age, HIV status and 
geographical location (Division) in Kampala; all were socially well networked, defined as 
having extensive social networks and being able to distribute coupons to a large number of 
peers. However, rates of recruitment were low throughout the study. Study recruitment was 
interrupted twice due to arrests of MSM in Kampala during the study period. In addition, six 
seeds were added in the course of the survey to improve sampling rates. A total of 455 
coupons (26.7%) were redeemed out of 1706 coupons issued. Of these, 281 recruits and 14 
seeds were eligible and participated in the survey. The longest recruitment wave was 11, and 
equilibrium for syphilis was reached after wave 4. The average degree size was 11.3.
Survey procedures are described in detail elsewhere.3 In brief, screened, eligible and 
consented participants responded to a standardised audio-computer assisted interview. The 
survey collected information on demographics and sexual behaviour in the 3 months 
preceding the interview. Sexual behaviour with male and female partners was queried by 
primary, steady, casual, anonymous, one-night stand, sex worker and client partner types. 
The survey also collected data on alcohol and drug use, violence and STI symptoms.
Blood specimens were collected from participants to test for syphilis; urine and rectal 
specimens were collected to test for gonorrhoea and chlamydia. Only 4 of the 295 
participants (1.4%) refused to provide rectal specimens, and no participants refused to 
provide urine. Antisyphilis IgG ELISA (Biotec Laboratories, Suffolk, UK) was used to 
screen plasma for lifetime exposure to Treponema pallidum (TP), and the Rapid Plasma 
Reagin Syfacard-R Test (Murex Biotech, Dartford, UK) was used to detect current TP 
infection. The presence of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) 
DNA was tested in urine specimens and rectal swabs using Cobas Amplicor or Amplicor 
PCR (Roche Diagnostics, Branchburg, New Jersey, USA). A parallel testing algorithm using 
Vironostika HIV Uniform II plus O2 (bioMeriéux, Marcy l'Etoile, France) and Murex HIV 
Ag/Ab Combination (Abbott Laboratories, Abbott Park, Illinois, USA) was used to test for 
HIV antibodies. HIV 1/2 STAT-PAK rapid test (Inverness Medical, Princeton, New Jersey, 
USA) was used to resolve discordant results. Laboratory tests were conducted at the STD 
Unit of Mulago Hospital, Kampala and the US Centers for Disease Control and Prevention 
laboratory in Entebbe, Uganda. Participants were asked to return after 2 weeks to receive 
their results; 61% of participants returned for a second visit. During these visits, participants 
received counselling for all biomarkers, were provided treatment for STIs and, if HIV-
positive, were referred to care and treatment providers.
Weighted univariate and bivariate analyses were conducted in RDS Analysis Tool (RDSAT) 
V.5.6 (http://www.respondentdrivensampling.org). Individual STI sampling weights were 
generated in RDSAT and exported to SAS V.9.2 (SAS Institute, Cary, North Carolina, USA) 
to perform additional bivariate and multivariate analyses. Missing data were dropped from 
analysis. Bivariate associations with STI diagnosis were assessed using survey-weighted 
Wald tests. Multivariate analysis was conducted using survey-weighted logistic regression 
with variables associated with positive STI diagnosis. Variables considered in the modelling 
process were those associated with STI diagnosis at a level of p≤0.2 in bivariate analysis. 
Other variables were included based on a conceptual framework incorporating previous 
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knowledge of association with STI risk. The final model was adjusted for age and education 
and those variables that were significantly associated with STI diagnosis.
Survey participation was anonymous: informed consent was obtained verbally and no 
personal identifiers were collected.
Results
A total of 295 MSM were included in the analysis. The majority of participants were under 
25 years of age: 19.8% were 18–20 years old and 42.9% were 21–25 years old (table 1). 
Most participants reported drinking alcohol every day or at least once a week (17.9% and 
43.8%, respectively), and 47.2% reported alcohol use before sex. Nearly a third of MSM 
(32.0%) reported having had an anonymous sex partner in the past 6 months, and 29.5% had 
sold sex in the 3 months prior to the survey.
A total of 47.3% reported any genital or anal STI symptoms in the last 6 months (table 1). 
Self-reported genital discharge and ulcer symptoms were common (29.5% and 31.6%, 
respectively). In addition, 25.0% reported anal ulcers and 12.6% reported anal discharge in 
the past 6 months. The majority of those reporting symptoms stopped having sex during 
symptom occurrence (61.2%).
Overall, 13.5% of participants were diagnosed with syphilis, rectal or urethral chlamydia, or 
rectal or urethral gonorrhoea (table 1). Prevalence of syphilis was the highest of the three 
infections (9.0%), while prevalence of chlamydia and gonorrhoea (rectal or urethral) ranged 
from 1.1% to 1.8%. Prevalence of HIV was 12.9%.
Table 2 shows weighted bivariate associations between select risk factors and laboratory-
confirmed STI diagnosis of syphilis, gonorrhoea, or chlamydia. Reported alcohol use before 
sex was positively associated with STI diagnosis (OR=2.99). None of the STI symptoms 
reported in the last 6 months were significantly associated with STI diagnosis. HIV infection 
was positively associated with STI diagnosis (OR=2.76).
Results of the multivariate analysis are shown in table 3. Adjusting for age and education, 
STI diagnosis remained positively associated with alcohol use before sex (adjusted OR 
(AOR)=4.99), selling sex in the last 3 months (AOR=3.17) and HIV infection (AOR=3.46). 
Having anonymous partners in the last 3 months was inversely associated with STI diagnosis 
(AOR=0.20).
Discussion
We found a high combined prevalence of STI diagnoses among MSM in Kampala, and very 
high rates of self-reported STI symptoms. Though few studies have been conducted to assess 
burden of STI among MSM populations in sub-Saharan Africa, our findings are consistent 
with levels of STI prevalence ranging from 2.6% to 23.7% found among MSM in Kenya, 
Tanzania and Senegal.8–12 Compared with the population in Uganda, prevalence of syphilis 
among MSM in this study was over four times that of the general male population aged 15–
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49 years in 2011.3 Overall, MSM in Kampala had a higher burden of STI than the general 
population.
MSM also reported higher levels of STI symptoms in the previous 12 months, two times the 
amount reported by men in the general population; 18.4% of men aged 15–49 years reported 
STI symptoms in the 12 months prior to the 2011 Uganda AIDS Indicator Survey.3 Though 
laboratory-confirmed diagnoses did not precisely match self-reported symptoms, some 
infections may have been missed due to the cross-sectional design of the survey. We also did 
not find significant associations between any self-reported symptom and STI diagnosis. 
Finally, a significant proportion of those with STI diagnoses did not report any symptoms, 
suggesting that syndromic surveillance and diagnostic approaches may not be effective in 
this population. Still, given the prevalence of STI and the frequency of self-reported STI 
symptoms in this population, STI prevention and treatment programmes as well as routine 
STI surveillance should specifically support MSM and other high-risk groups and provide 
guidance on recognising urethral and rectal STI symptoms. To detect asymptomatic 
infections, routine STI testing should be provided to MSM based on reported risk behaviours 
and healthcare workers should be trained to provide STI services in a non-stigmatising 
environment.13 MSM should be educated to seek treatment if they experience symptoms of 
STI, and messages regarding preventive behaviours to reduce transmission to partners 
should be reinforced. Given the association between STI and HIV infection, HIV care and 
treatment services should also provide comprehensive counselling and screening for STI.
Overall, regular alcohol use among MSM was common, and nearly half reported using 
alcohol before sex, which was significantly associated with STI. This association has been 
reported in other populations, including female sex workers and the general population.14–16 
Though our study did not find significant interactions between unprotected sex and alcohol 
use, alcohol use has been linked to sex work and other risky sexual behaviours such as 
unprotected sex.1718 The use of alcohol before sex may lead to loss of inhibition, thus 
increasing risk-taking behaviours. Alcohol may also increase susceptibility to HIV and other 
infections and worsen disease course by impairing immunity.19 Counselling messages for 
this population should incorporate harm reduction material regarding the risks associated 
with alcohol use with sex.
We found that participants who reported having anonymous sex partners in the 6 months 
before the survey were less likely to be diagnosed with a STI than those who did not have 
anonymous partners. It is possible that MSM recognise higher infection risk with 
anonymous partners and are more likely to practice preventive behaviours with these 
partners, such as using condoms.20 However, risk behaviours have also been found to be 
associated with having anonymous partners.21 Our study may have been limited in assessing 
confounders in the relationship between STI and having anonymous sex partners. This 
association should be examined further using qualitative and quantitative methodologies.
This study had a number of limitations. Levels of stigma and discrimination of MSM in 
Uganda are high, and harassment of MSM, while unrelated to this study, adversely affected 
study participation. Though RDS is designed to capture a representative sample of the target 
population, RDS is based on a number of assumptions that may not have been met because 
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this discrimination may have biased recruitment towards a certain subgroup of MSM. Thus, 
the findings of this study may not represent the larger MSM population in Kampala. Given 
the limitations of the data, it is difficult to ascertain whether the assumptions of RDS, 
specifically that respondents recognise each other as members of the population, respondent 
networks are linked and form a single component, and the sampling fraction is small, were 
fulfilled.22 In addition, the survey design was cross-sectional, limiting our ability to 
determine causal associations between risk factors and STI diagnoses. While study findings 
on multivariate associations were significant, CIs were wide due to the small sample size. 
STI symptoms and other risk behaviours were self-reported for the previous 3 months, 6 
months or 12 months, while laboratory-confirmed diagnoses of STIs only reflected infection 
at the time of testing. With regards to PCR testing for NG and CT, we cannot rule out the 
possibility of some false-positive results, though the estimated prevalence was relatively low. 
Further, the assay we used is not approved for use on rectal specimens without further 
confirmation of positive test results. Finally, syphilis and rectal and urethral infections of NG 
and CTwere combined for our outcome variable. Although these infections are all current 
and reflect bacterial illness, it is possible that the epidemiology of each type of infection 
differs from one another.
This first round of biobehavioural surveillance among MSM in Kampala demonstrated the 
feasibility of conducting surveys with biological testing and the public health need related to 
STI and HIV infection in this highly stigmatised key population. We observed high 
prevalence of syphilis, NG and CT, and found high levels of self-reported STI symptoms. 
Our findings support the need for public health interventions specific to MSM to address 
risk behaviours related to alcohol use, STI transmission, identification of STI through 
symptom screening and testing, STI surveillance, and STI treatment-seeking behaviours. 
Finally, contextual factors including cultural perceptions and government policy in Uganda 
should be addressed to improve public health outcomes in this population.
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Key messages
• Levels of self-reported STI symptoms and STI prevalence among MSM were 
high.
• STI among MSM was associated with HIV and risky sexual behaviours, 
including alcohol use before sex and selling sex.
• Public health interventions are needed to address STI risk and facilitate access to 
diagnosis and treatment services among MSM.
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Table 1
Sociodemographic and behavioural variables and sexually transmitted infections (STIs) 
among men who have sex with men in Kampala, Uganda
n (unweighted) Sample % (unweighted)
Estimated 
population 
proportion % 
(weighted) 95% CI
Age (years)
 18–20 52 18.1 19.8 12.9 to 27.4
 21–25 111 38.5 42.9 32.9 to 49.0
 26–30 70 24.3 22.9 17.0 to 32.0
 >30 55 19.1 14.5 9.6 to 21.6
Education
 None 22 7.8 7.9 4.5 to 11.9
 1–7 years 72 25.4 28.3 20.3 to 36.0
 8–11 years 58 20.4 23.7 17.2 to 31.4
 12 or more years 131 46.5 40.2 31.3 to 49.5
Drink alcohol, past 30 days
 About every day 53 18.5 17.9 11.1 to 25.8
 At least once a week 124 43.4 43.8 36.8 to 51.2
 Less than once a week 24 8.4 10.2 5.1 to 16.5
 None 85 29.7 28.1 21.4 to 35.2
Sexual orientation
 Gay/homosexual 162 56.3 54.2 47.5 to 62.6
 Bisexual 113 39.2 38.8 30.8 to 45.4
 Straight/heterosexual 13 4.5 7.0 2.6 to 12.9
Alcohol use before sex
 Yes 123 43.2 47.2 38.5 to 56.0
 No
Had anonymous sex partner in the past 3 months
 Yes 107 37.3 32.0 24.8 to 40.1
 No 180 62.7 68.0 59.9 to 75.2
Ever sold sex
 Yes 128 44.4 39.3 29.5 to 46.2
 No 160 55.6 60.7 53.8 to 70.5
Sold sex in the past 3 months
 Yes 94 31.8 29.5 21.9 to 35.8
 No 179 60.5 70.5 64.2 to 78.1
Used condom during insertive anal sex in the past 
3 months
 Yes 173 65.8 66.5 58.2 to 74.3
 No 90 34.2 33.5 25.7 to 41.8
Used condom during receptive anal sex in the past 
3 months
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n (unweighted) Sample % (unweighted)
Estimated 
population 
proportion % 
(weighted) 95% CI
 Yes 140 60.1 62.4 53.7 to 70.1
 No 93 39.9 37.6 29.9 to 46.3
STI symptoms in the past 12 months
Genital discharge
 Yes 86 30.6 29.5 21.9 to 37.3
 No 195 69.4 70.5 62.7 to 78.1
Genital ulcers
 Yes 93 33.6 31.6 23.6 to 39.3
 No 184 66.4 68.4 60.7 to 76.4
Anal ulcers
 Yes 79 28.7 25.0 18.7 to 32.6
 No 196 71.3 75.0 67.4 to 81.3
Anal discharge
 Yes 45 16.3 12.6 8.3 to 18.1
 No 232 83.8 87.4 81.9 to 91.7
Anal warts
 Yes 57 21.4 16.6 11.1 to 22.2
 No 210 78.7 83.4 77.8 to 88.9
Any STI symptom
 Yes 143 51.8 47.3 39.3 to 56.0
 No 133 48.2 52.7 44.0 to 60.7
Stopped having sex with symptoms
 Yes 73 54.1 61.2 49.8 to 73.1
 No 62 45.9 38.8 26.9 to 50.2
Lab results
Syphilis
 Positive 30 10.3 9.0 5.5 to 13.3
 Negative 260 89.7 91.0 86.7 to 94.5
Rectal chlamydia
 Positive 3 1.1 1.1 0 to 2.7
 Negative 283 99.0 98.9 97.3 to 100.0
Urethral chlamydia
 Positive 3 1.0 1.2 0 to 2.9
 Negative 285 99.0 98.8 97.1 to 100.0
Rectal gonorrhoea
 Positive 5 1.8 1.8 0.2 to 4.2
 Negative 281 98.3 98.2 95.8 to 99.8
Urethral gonorrhoea
 Positive 4 1.4 1.4 0.2 to 3.0
 Negative 284 98.6 98.6 97.0 to 99.8
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n (unweighted) Sample % (unweighted)
Estimated 
population 
proportion % 
(weighted) 95% CI
Any STI
 Positive 42 14.8 13.5 9.2 to 19.3
 Negative 242 85.2 86.5 80.7 to 90.8
HIV serostatus
 Positive 39 13.5 12.9 7.2 to 19.5
 Negative 251 86.6 87.1 80.5 to 92.8
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Table 3
Factors associated with sexually transmitted infection among men who have sex with men 
in Kampala, Uganda (n=257)
Unadjusted ORs (95% CI) Adjusted ORs (95% CI)
Age (years)
 18–20 Ref. Ref.
 21–25 0.64 (0.20 to 2.07) 0.36 (0.11 to 1.15)
 26–30 0.78 (0.25 to 2.47) 0.29 (0.07 to 1.24)
 >30 1.49 (0.47 to 4.67) 0.85 (0.22 to 3.22)
Years of schooling
 None Ref.
 1–7 years 0.91 (0.23 to 3.61) 0.82 (0.16 to 4.20)
 8–11 years 0.64 (0.15 to 2.72) 0.52 (0.08 to 3.63)
 12 or more years 0.85 (0.26 to 2.84) 0.88 (0.18 to 4.42)
Had anonymous sex partner in the past 3 months
 Yes 0.53 (0.22 to 1.26) 0.20 (0.07 to 0.61)
 No Ref. Ref.
Alcohol use before sex
 Yes 2.99 (1.28 to 6.96) 4.99 (1.86 to 13.38)
 No Ref. Ref.
Sold sex in the past 3 months
 Yes 1.57 (0.66 to 3.74) 3.17 (1.25 to 8.07)
 No Ref. Ref.
HIV status
 Positive 2.76 (0.98 to 7.80) 3.46 (1.03 to 11.64)
 Negative Ref. Ref.
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